UCL-GSK Phenomics Hub

Last updated on Nov 23, 2023
Go to Project Site

Phenotyping at scale across diverse biobank cohorts to power genomic & proteomic analyses for target identification, drug discovery, and precision medicine.

Core team

  • GSK: Jonathan Davitte, Damien C. Croteau-Chonka, Paul A. Wilson
  • UCL: Spiros Denaxas, Ana Torralbo, Natalie Fitzpatrick, Cai Ytsma, Natalie Zelenka

Collaborators

  • GSK: Robert A. Scott, Chloe Robins, Joanna C. Betts, Praveen Surendran, Tokuwa Kanno, Stephan Gade, Daniel Freitag, Frederik Ziebell
  • QMUL: Claudia Langenberg, Maik Pietzner, Julia Carrasco-Zanini
  • UCL: Harry Hemingway
  • University of Cambridge: Nicholas J. Wareham

Selected works

Proteomic prediction of common and rare diseases
section { background: white; color: black; border-radius: 1em; padding: 1em; left: 50% } #inner { display: inline-block; display: flex; align-items: center; justify-content: center } Twitter thread summarising key results
Julia Carrasco-Zanini, Maik Pietzner, Jonathan Davitte, Praveen Surendran, Damien C. Croteau-Chonka, Chloe Robins, Ana Torralbo, Chris Tomlinson, Natalie Fitzpatrick, Cai Ytsma, Tokuwa Kanno, Stephan Gade, Daniel Freitag, Frederik Ziebell, Spiros Denaxas, Joanna C. Betts, Nicholas J. Wareham, Harry Hemingway, Robert A. Scott, Claudia Langenberg
PDF Dataset DOI
phenomics EHR Health data science UK Biobank Genes & Health UCL-GSK Phenomics Hub UK Biobank Pharma Proteomics Project Omics Genomics Proteomics Industry collaboration GSK Risk prediction Machine Learning PheWAS GWAS Drug discovery Target identification
Chris Tomlinson
Chris Tomlinson

MBBS BSc MRes DMCC MRCA

Senior Research Fellow in Health Data Science

Related